GCC Syringes & Needles Market, By Product Type (Oral, Hypodermic (Standard, Special Purpose (Insulin, Tuberculin, Angiographic, Others))), By Usability (Disposable, Reusable), By Material (Glass, Polymer), By End User (Hospital, Blood Collection Centers,

GCC Syringes & Needles Market, By Product Type (Oral, Hypodermic (Standard, Special Purpose (Insulin, Tuberculin, Angiographic, Others))), By Usability (Disposable, Reusable), By Material (Glass, Polymer), By End User (Hospital, Blood Collection Centers, Diabetic Care Center, Veterinary Care Center, Others) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Syringes are medical devices used to inject fluid or withdraw fluid from the body. A medical syringe consists of a needle attached to a hollow cylinder that is fitted with a sliding plunger. They are mainly made from plastic and disposables and are majorly used in the healthcare practices. High-end syringes such as microliter syringes are made from glass material. Increasing utilization of medical test for diagnosis of diseases that requires intravenous modes of injection using syringes is major factor driving growth of the syringes market. According to National Health Council, around 75% of the total healthcare costs are a result of chronic diseases reflecting an increasing demand for proper healthcare requirements in terms of quality, safety, and sterility of medical devices. According to the same source, in 2014, around 133 million people were affected with chronic diseases in the U.S.
Restraints of the GCC Syringes & Needles Market
Restraining factors such as reuse of disposable syringes, and interaction of prefilled syringes with drugs is expected to restrain GCC syringes & needles market growth over the forecast period.
Key features of the study:
This report provides in-depth analysis of the GCC syringes & needles market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the GCC syringes & needles market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Becton, Dickinson and Company (BD), Nipro Corporation, Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Medtronic plc., Smiths Group plc., Abu Dhabi Medical Devices Company, SAAPP (FZC) LLC., and IBN Sina Medical Factory
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The GCC syringes & needles market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
GCC Syringes & Needles Market, By Product Type:
Oral
Hypodermic
Standard
Special Purpose
Insulin
Tuberculin
Angiographic
Others
GCC Syringes & Needles Market, By Usability:
Disposable
Reusable
GCC Syringes & Needles Market, By Material:
Glass
Polymer
GCC Syringes & Needles Market, End User:
Hospital
Blood Collection Centers
Diabetic Care Center
Veterinary Care Center
Others
GCC Syringes & Needles Market, By Country:
KSA
By Product Type
Oral
Hypodermic
Standard
Special Purpose
Insulin
Tuberculin
Angiographic
Others
By Usability:
Disposable
Reusable
By Material:
Glass
Polymer
By End User
Hospital
Blood Collection Centers
Diabetic Care Center
Veterinary Care Center
Others
UAE
By Product Type
Oral
Hypodermic
Standard
Special Purpose
Insulin
Tuberculin
Angiographic
Others
By Usability:
Disposable
Reusable
By Material:
Glass
Polymer
By End User
Hospital
Blood Collection Centers
Diabetic Care Center
Veterinary Care Center
Others
Qatar
By Product Type
Oral
Hypodermic
Standard
Special Purpose
Insulin
Tuberculin
Angiographic
Others
By Usability:
Disposable
Reusable
By Material:
Glass
Polymer
By End User
Hospital
Blood Collection Centers
Diabetic Care Center
Veterinary Care Center
Others
Bahrain
By Product Type
Oral
Hypodermic
Standard
Special Purpose
Insulin
Tuberculin
Angiographic
Others
By Usability:
Disposable
Reusable
By Material:
Glass
Polymer
By End User
Hospital
Blood Collection Centers
Diabetic Care Center
Veterinary Care Center
Others
Oman
By Product Type
Oral
Hypodermic
Standard
Special Purpose
Insulin
Tuberculin
Angiographic
Others
By Usability:
Disposable
Reusable
By Material:
Glass
Polymer
By End User
Hospital
Blood Collection Centers
Diabetic Care Center
Veterinary Care Center
Others
Kuwait
By Product Type
Oral
Hypodermic
Standard
Special Purpose
Insulin
Tuberculin
Angiographic
Others
By Usability:
Disposable
Reusable
By Material:
Glass
Polymer
By End User
Hospital
Blood Collection Centers
Diabetic Care Center
Veterinary Care Center
Others
Company Profiles
Becton, Dickinson and Company *
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Nipro Corporation
Baxter International Inc.
B. Braun Melsungen AG
Terumo Corporation
Medtronic plc
Smiths Group plc.
Abu Dhabi Medical Devices Company
SAAPP (FZC) LLC.
IBN Sina Medical Factory
“*” marked represents similar segmentation in other categories in the respective section.